ocular disease

Clover Health's new subsidiary will rely on members, machine learning to fuel drug development
By Dave Muoio | 05:13 pm | July 10, 2019
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.